Northwestern University
Chicago, Illinois, 60611, United States
NCT Number: NCT04957277
The purpose of this study is to investigate lower limb impairments in children with bilateral cerebral palsy during stepping tasks.
This study is active but is not currently recruiting participants.
Notify Me5 year–19 year
All sexes
Interventional
Not applicable
Chicago, Illinois, 60611, United States
Individuals with bilateral cerebral palsy (BCP) sustain a neonatal brain injury that leads to altered neuromuscular control to the lower limbs. One commonly observed motor impairment from this altered control is loss of selective voluntary motor control (SVMC), defined as the ability to independently move the joints intentionally. Loss of SVMC typically manifests as knee and ankle joint impairment and abnormal coupling between the hip adductors and lower limb extensors. This can make stepping up or down a curb or stair challenging, but quantitative investigation in these closed-chain activities has been limited. This is especially important as performance in stair-climbing is associated with limitations to overall mobility and community participation in cerebral palsy.
The overall aim of this proposal is to investigate the altered neuromuscular control that challenges stair walking in individuals with BCP. Participants who consent to the study will be instructed to perform multiple step-ups and step-downs on a single raised platform. The parameters of the stepping task may change by adding weight to the body or subtracting weight from the body. Using standard gait analysis techniques, biomechanical metrics such as joint kinematics and kinetics will be analyzed.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Adding body weight (BW) up to 20% BW and subtracting body weight down to -20% BW
Time frame: At baseline and each loading level; During entirety of the stepping trial, from initial lift-off to final contact onto the single platform.
Sum of the joint kinetics from the hip, knee and ankle, termed the "support moment" and measured in Nm.
Time frame: At baseline and each loading level; During entirety of the stepping trial, from initial lift-off to final contact onto the single platform.
hip torque (measured in Nm) will be identified for the hip, knee, and ankle during the duration of the task.
Time frame: At baseline and each loading level; During entirety of the stepping trial, from initial lift-off to final contact onto the single platform.
Knee angle (between the thigh and shank measured in degrees) will be identified during the duration of the task.
Time frame: At baseline and each loading level; During entirety of the stepping trial, from initial lift-off to final contact onto the single platform.
Ankle angle (between the shank and foot measured in degrees) will be identified during the duration of the task.
Time frame: At baseline and each loading level; During entirety of the stepping trial, from initial lift-off to final contact onto the single platform.
EMG data will be identified for underlying muscles of the hip during the stance phases of the task.
Time frame: At baseline and each loading level; During entirety of the stepping trial, from initial lift-off to final contact onto the single platform.
EMG data will be identified for underlying muscles of the knee during the stance phases of the task.
Time frame: At baseline and each loading level; During entirety of the stepping trial, from initial lift-off to final contact onto the single platform.
EMG data will be identified for underlying muscles of the ankle during the stance phases of the task.
Northwestern University
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05229523
Brain Damage, Chronic, Brain Diseases
Kahramanmaraş, Turkey (Türkiye)
View Trial DetailsNCT05213039
Brain Damage, Chronic, Brain Diseases
Kahramanmaraş, Turkey (Türkiye)
View Trial DetailsNCT02137005
Brain Damage, Chronic, Brain Diseases
Aurora, Colorado, United States
View Trial DetailsNCT05417399
Brain Damage, Chronic, Brain Diseases
Enschede, Overijssel, Netherlands
View Trial Details